The important prognostic information provided by CMR post TAVR
- ARTICLES
- diciembre 16, 2015
s
FOURIER is a mega-trial of clinical efficacy and safety of evolocumab added to treatment with moderate / high intensity statins in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD).
LEER MÁS